Safety, efficacy, and changing trends in endoscopic ablation for dysplastic Barrett esophagus in Poland: a long-term multicenter retrospective analysis

Endoscopic ablation is the mainstay of treatment for dysplastic Barrett esophagus (BE), of which radiofrequency ablation (RFA) and argon plasma coagulation (APC) are the most widely available options. We aimed to analyze the safety and outcomes of endoscopic ablation for BE at the Polish centers off...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Polskie archiwum medycyny wewne̦trznej Ročník 135; číslo 1
Hlavní autoři: Romanczyk, Marcin, Klimkowski, Robert, Kukla, Michal, Pilonis, Nastazja D, Romanczyk, Tomasz, Gorecka, Magda, Lesinska, Magdalena, Wronska, Ewa, Regula, Jaroslaw, Kaminski, Michal F, Januszewicz, Wladyslaw
Médium: Journal Article
Jazyk:angličtina
Vydáno: Poland 30.01.2025
Témata:
ISSN:1897-9483
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Endoscopic ablation is the mainstay of treatment for dysplastic Barrett esophagus (BE), of which radiofrequency ablation (RFA) and argon plasma coagulation (APC) are the most widely available options. We aimed to analyze the safety and outcomes of endoscopic ablation for BE at the Polish centers offering this procedure. We retrospectively analyzed data from 3 high‑volume endoscopy centers between 2002 and 2024. We included adult patients with confirmed BE who received at least 1 ablation session with either conventional / hybrid APC (APC/h‑APC) or RFA, followed by at least 1 endoscopic follow‑up. The outcomes included the rate of complete remission of intestinal metaplasia (CR‑IM) and dysplasia (CR‑D), and adverse event (AE) rate. Risk factors for treatment failure were analyzed using a multivariable logistic regression model. We analyzed data from 191 patients, of which 160 were included (mean [SD] age, 59.4 [10.8] years; 79.4% men). The overall CR‑IM and CR‑D rates were 80% and 93.8%, respectively. We reported 49 minor AEs (30.6%), and 9 major AEs (5.6%), including 7 esophageal strictures (4.4%). In the early 2000s, APC was the only available ablation modality. However, since 2008, it has been gradually replaced by RFA. Notably, RFA was used for more severe BE cases and carried a higher risk of failed treatment than APC/h‑APC (odds ratio [OR], 7.48; P = 0.001). Other risk factors for treatment failure included the BE length (OR, 1.3; P = 0.002) and diabetes (OR, 7.48; P <0.001). Endoscopic ablation for BE is safely and effectively provided in Poland at a few expert centers. Patients with diabetes and long‑segment BE are at an increased risk for treatment failure.
AbstractList Endoscopic ablation is the mainstay of treatment for dysplastic Barrett esophagus (BE), of which radiofrequency ablation (RFA) and argon plasma coagulation (APC) are the most widely available options. We aimed to analyze the safety and outcomes of endoscopic ablation for BE at the Polish centers offering this procedure. We retrospectively analyzed data from 3 high‑volume endoscopy centers between 2002 and 2024. We included adult patients with confirmed BE who received at least 1 ablation session with either conventional / hybrid APC (APC/h‑APC) or RFA, followed by at least 1 endoscopic follow‑up. The outcomes included the rate of complete remission of intestinal metaplasia (CR‑IM) and dysplasia (CR‑D), and adverse event (AE) rate. Risk factors for treatment failure were analyzed using a multivariable logistic regression model. We analyzed data from 191 patients, of which 160 were included (mean [SD] age, 59.4 [10.8] years; 79.4% men). The overall CR‑IM and CR‑D rates were 80% and 93.8%, respectively. We reported 49 minor AEs (30.6%), and 9 major AEs (5.6%), including 7 esophageal strictures (4.4%). In the early 2000s, APC was the only available ablation modality. However, since 2008, it has been gradually replaced by RFA. Notably, RFA was used for more severe BE cases and carried a higher risk of failed treatment than APC/h‑APC (odds ratio [OR], 7.48; P = 0.001). Other risk factors for treatment failure included the BE length (OR, 1.3; P = 0.002) and diabetes (OR, 7.48; P <0.001). Endoscopic ablation for BE is safely and effectively provided in Poland at a few expert centers. Patients with diabetes and long‑segment BE are at an increased risk for treatment failure.
Author Regula, Jaroslaw
Januszewicz, Wladyslaw
Pilonis, Nastazja D
Wronska, Ewa
Klimkowski, Robert
Lesinska, Magdalena
Gorecka, Magda
Romanczyk, Marcin
Kukla, Michal
Kaminski, Michal F
Romanczyk, Tomasz
Author_xml – sequence: 1
  givenname: Marcin
  surname: Romanczyk
  fullname: Romanczyk, Marcin
  organization: Endoterapia, H-T. Centrum Medyczne, Tychy, Poland
– sequence: 2
  givenname: Robert
  surname: Klimkowski
  fullname: Klimkowski, Robert
  organization: Department of Gastroenterology, Hepatology, and Clinical Oncology, Center of Postgraduate Medical Education, Warszawa, Poland
– sequence: 3
  givenname: Michal
  surname: Kukla
  fullname: Kukla, Michal
  organization: Department of Internal Medicine and Geriatrics, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
– sequence: 4
  givenname: Nastazja D
  surname: Pilonis
  fullname: Pilonis, Nastazja D
  organization: Department of Gastroenterology, Hepatology, and Clinical Oncology, Center of Postgraduate Medical Education, Warszawa, Poland
– sequence: 5
  givenname: Tomasz
  surname: Romanczyk
  fullname: Romanczyk, Tomasz
  organization: Endoterapia, H-T. Centrum Medyczne, Tychy, Poland
– sequence: 6
  givenname: Magda
  surname: Gorecka
  fullname: Gorecka, Magda
  organization: Department of Endoscopy, University Hospital in Krakow, Kraków, Poland
– sequence: 7
  givenname: Magdalena
  surname: Lesinska
  fullname: Lesinska, Magdalena
  organization: Endoterapia, H-T. Centrum Medyczne, Tychy, Poland
– sequence: 8
  givenname: Ewa
  surname: Wronska
  fullname: Wronska, Ewa
  organization: Department of Gastroenterology, Hepatology, and Clinical Oncology, Center of Postgraduate Medical Education, Warszawa, Poland
– sequence: 9
  givenname: Jaroslaw
  surname: Regula
  fullname: Regula, Jaroslaw
  organization: Department of Gastroenterology, Hepatology, and Clinical Oncology, Center of Postgraduate Medical Education, Warszawa, Poland
– sequence: 10
  givenname: Michal F
  surname: Kaminski
  fullname: Kaminski, Michal F
  organization: Department of Gastroenterology, Hepatology, and Clinical Oncology, Center of Postgraduate Medical Education, Warszawa, Poland
– sequence: 11
  givenname: Wladyslaw
  surname: Januszewicz
  fullname: Januszewicz, Wladyslaw
  email: wjanuszewicz@cmkp.edu.pl
  organization: Department of Oncological Gastroenterology, Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland; Department of Gastroenterology, Hepatology, and Clinical Oncology, Center of Postgraduate Medical Education, Warszawa, Poland. wjanuszewicz@cmkp.edu.pl
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39745401$$D View this record in MEDLINE/PubMed
BookMark eNo1kFtLxDAQhYMo7kWffJf8ALumadqkvuniDRYU1Odl2ky7kTYpTVbpL_HvGrw8nZnDOd_ALMihdRYJOUvZijOR88sB-s9VWpQpPyDzVJUyKYXKZmTh_TtjRZkpeUxmWSlFLlg6J18v0GCYLig2jamhjhNYTesd2NbYloYRrfbUWBrV-doNpqZQdRCMs7RxI9WTHzrwIfo3MI4YAkXvhh20-5_es-si8YoC7Zxtk4BjT_t9F_No40JjY3R-wDqYD4zHoZu88SfkqIHO4-mfLsnb3e3r-iHZPN0_rq83yZBKFRLOUYtcclYxnVU5R5milpKjYkrlGW8EL3IhC2SAGoXgVQ2FRp6CViUi8iU5_-UO-6pHvR1G08M4bf8_xL8BskNr8w
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.20452/pamw.16912
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1897-9483
ExternalDocumentID 39745401
Genre Multicenter Study
Journal Article
GeographicLocations Poland
GeographicLocations_xml – name: Poland
GroupedDBID 36B
3EA
5VS
ABMXE
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
EBD
ECM
EIF
EMB
EMOBN
EOJEC
F5P
KQ8
NPM
OBODZ
OK1
RNS
SV3
Y2W
ID FETCH-LOGICAL-p178t-22ed45720b0d3b52e71ed772e8088532f4265476e0aede442bca6de21ad89eee2
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001438691900023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Thu May 29 04:59:33 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p178t-22ed45720b0d3b52e71ed772e8088532f4265476e0aede442bca6de21ad89eee2
PMID 39745401
ParticipantIDs pubmed_primary_39745401
PublicationCentury 2000
PublicationDate 2025-Jan-30
PublicationDateYYYYMMDD 2025-01-30
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-Jan-30
  day: 30
PublicationDecade 2020
PublicationPlace Poland
PublicationPlace_xml – name: Poland
PublicationTitle Polskie archiwum medycyny wewne̦trznej
PublicationTitleAlternate Pol Arch Intern Med
PublicationYear 2025
SSID ssj0069387
Score 2.3392155
Snippet Endoscopic ablation is the mainstay of treatment for dysplastic Barrett esophagus (BE), of which radiofrequency ablation (RFA) and argon plasma coagulation...
SourceID pubmed
SourceType Index Database
SubjectTerms Adult
Aged
Argon Plasma Coagulation
Barrett Esophagus - surgery
Catheter Ablation
Esophagoscopy
Female
Humans
Male
Middle Aged
Poland
Radiofrequency Ablation
Retrospective Studies
Treatment Outcome
Title Safety, efficacy, and changing trends in endoscopic ablation for dysplastic Barrett esophagus in Poland: a long-term multicenter retrospective analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/39745401
Volume 135
WOSCitedRecordID wos001438691900023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LjtMwFLU6gEazQbzfyAtm1QkkzsMJu6ECsYCqEgOa3ciJb0aZpknUdiaT_ggfyI9wHcdJqYSABZukiuvE8T2yr-NzzyXklWMLL_UCx0oc27a8IOVWhJ69JdMkcUOZctlq6X37xKfT8PQ0mo1GP0wszFXOiyK8vo6q_2pqvIbGVqGz_2Du_qZ4AX-j0fGIZsfjXxn-i0hBK_2DkocQSWMYmm2Qr84LYYiweC5VYIpSbY3zgXgom1WFfrVSc32nybxjUAkPxPllW29WtozINlI6L4tzS43wmp2o6J6wHGOdZWniOPHxWvtk2xfGe6zmGZapvYz6cqH2-ZukKZpxDXUBh5PJ4XGwXm4KuBi2hVSIw6aZd2FGSTaQCPJsMS_rLg23JowP-1TzXPRBAj2nZJZh07XGwhTfVWwuREeA7j6DMMU4NDs6oIfuMEKceTotTj-2ay2UbRDvzhlKj5-1mY4X9WslHcS2_4UdWS1apKDjptQKnT-X7gh4m6I9sscDNXdM1Qcl7SwEkRtyHTbatuPN0IoDsm9q7ix5Wtfn5A653a1Z6LHG2l0yguIe2f_csTLuk-8ackfUAO6IIjiogRvVcKNZQQe4UQM3inCjA9xoBzfaw03V03B7SwXtwUa3wEZ_ARs1YHtAvn54fzL5aHUJP6zK4eHaYgyk53Nmx7Z0Y58Bd0Di8g9CnAt9l6XoTvoeD8AWIMHzWJyIQAJzhAwjAGAPyY2iLOAxoX4iRBpEAsca4YGMQ8ClkVJbFMJzU-4_IY90l55VWtXlzHT209-WPCMHA_Kek5spjhjwgtxKrtbZavmyNexPmAGaHg
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety%2C+efficacy%2C+and+changing+trends+in+endoscopic+ablation+for+dysplastic+Barrett+esophagus+in+Poland%3A+a+long-term+multicenter+retrospective+analysis&rft.jtitle=Polskie+archiwum+medycyny+wewne%CC%A6trznej&rft.au=Romanczyk%2C+Marcin&rft.au=Klimkowski%2C+Robert&rft.au=Kukla%2C+Michal&rft.au=Pilonis%2C+Nastazja+D&rft.date=2025-01-30&rft.eissn=1897-9483&rft.volume=135&rft.issue=1&rft_id=info:doi/10.20452%2Fpamw.16912&rft_id=info%3Apmid%2F39745401&rft_id=info%3Apmid%2F39745401&rft.externalDocID=39745401